TURKISH JOURNAL OF MEDICAL SCIENCES, vol.47, no.3, pp.1037-1044, 2017 (SCI-Expanded)
Background/aim: Gemcitabine (GEM) has antiproliferative effects on lymphocytes, which are potent pathogenic actors of rheumatoid arthritis (RA). The aim of the study was to investigate the therapeutic potential of GEM on collagen-induced arthritis (CIA).